Homocysteine (Hyc) in prediabetes: An early indicator of Cardiovascular disease

References

1. European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?Study Group. 2003;26:688–96.
2. Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.Diabetes Res Clin Pract. 2007;78(3):305–12.
3. Surdacki A, Stochmal E, Szurkowska M, Bode-Bger SM, Martens- Lobenhoffer J. Nontraditional atherosclerotic risk factors and extent of coronary atherosclerosis in patients with combined impaired fasting glucose and impaired glucose tolerance.Metabolism. 2007;56(1):77–
4. Levitan EB, Song Y, Ford ES, Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies.Arch Intern Med. 2004;164:2147–55.
5. Defronzo RA, M AG. Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose.Am J Cardiol. 2011;108(3):3–24. Suppl.
6. Gerstein HC. Glucose: a continuous risk factor for cardiovascular disease.Diabet Med. 1997;14(3):25–31. Suppl.
7. Munshi MN, Stone A, Fink L, Fonseca V. Hyperhomocysteine- mia following a methionine load in patients with non-insulin- dependent diabetes mellitus and macrovascular disease.Metabolism. 1996;45(1):133–5.
8. Catena C, Colussi G, Nait F. Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients.Am J Hypertens. 2015;28(7):943–50.
9. Welch GN, Loscalzo J. Homocysteine and atherothrombosis.N Engl J Med. 1998;338:1042–1050.
10. Hoogeveen EK, Kostense PJ, Beks PJ, Mackaay AJ, Jakobs C, et al. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study.Arterioscler Thromb Vasc Biol. 1998;18:133–8.
11. Hoogeveen EK, Kostense PJ, Jakobs C, Dekker JM, Nijpels G, Heine RJ. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn Study.Circulation. 2000;101:1506–11.
12. Okada E, Oida K, Tada H, Asazuma K, Eguchi K, et al. Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes.Diabetes Care. 1999;22:484–
13. Stehouwer CD, Gall MA, Hougaard P, Jakobs C, Parving HH. Plasma homocysteine concentration predicts mortality in non-insulin- 352 Bidwe, Hisalkar and Mallick / International Journal of Clinical Biochemistry and Research 2019;6(3):348–352 dependent diabetic patients with and without albuminuria.Kidney Int. 1999;55:308–314.
14. Mahalle N, Kulkarni MV, Garg MK, Naik SS. Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease.J Cardiol. 2013;61(4):289–94.
15. Welch GN, Loscalzo J. Homocysteine and atherothrombosis.N Engl J Med. 1998;338(15):1042–50.
16. Starkebaum G, Harlan JM. Endothelial cell injury due to copper- catalyzed hydrogen peroxide generation from homocysteine.J Clin Invest. 1986;77(4):1370–6.
17. Zeng X, Dai J, Remick DG, Wang X. Homocysteine-mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes.Circ Res. 2003;93(4):311–20.
18. Kaplan L. Carbohydrates and metabolite, In Clinical Chemistry: theory, Analysis and co-relation. KLA, , PAJ, obsy ECV, editors. Toronto ; 1984,.
19. Allain CC, Poon L. Enzymatic Determination of Total Serum Cholesterol.Clin Chem. 1974;20:470.
20. Bachorik PS, Albers JJ, Rifal N. Editors Tietz Textbook of Clinical Chemistry. 3rd ed. . CA B, ER A, editors. Philadelphia: W.B Saunders Company ; 1999,. Lipoproteins and apolipoproteins. 3rd ed.
21. Williams P, Robinson D, Bailey A. High density of lipoprotein and coronary risk factor in normal man.Lancet. 1979;1:72.
22. Edited by the Japan Diabetes Society: Treatment Guide for Diabetes
23. Bunkodo ; 2010,.
24. Thambyrajah J, Townend JN. Homocysteine and atherothrombo- sis—mechanisms for injury .Europian Heart J. 2000;21(12):967–74.
25. Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, et al. Fasting Plasma Homocysteine Levels in the Insulin Resistance Syndrome. Diabetes Care. 2001;24:1403–10.
26. Faeh D, Chiolero A, Paccaud F ;.
27. Kanani PM, Sinkey CA, Browning RL, Allaman M, Knap HR, et al. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocysteinemia in humans.Circ. 1999;100:1161–8.
28. Tawakol A, Omland T, Wujt GM, Creager MA. Hyperhomocysteine- mia is associated with impaired endothelium-dependent vasodilation in humans.Circ. 1997;95:1119–21.
29. Malinow MR, Neito FJ, Szklo M, Chambless LE, Bond G. Caroitd artery intimal-medial wall thickening and plasma homocysteinemia is asymptomatic adults. The Atherosclerosis Risk in Communities Study.Circulation. 1993;87:1107–1113.
30. Majors A, Ehrhart LA, Pezacka EH. Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells.ArteriosclerThrombVasc Biol. 1997;17:2074–
31. Voutilainen S, Morrow JD, G Roberts Lj 2nd A, Alho H, Nyyssonen K. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels.Arterioscler Thromb Vasc Biol. 1999;19:1263–6.
32. Lentz SR. Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost. 2005;8:1646–54.
33. Shaikh MK, Devrajani BR, Shaikh A, Shah S, Shaikh S. Plasma Homocysteine Level in Patients with Diabetes mellitus.World Applied Sciences Journal. 2012;16(9):1269–1273.
34. Feng X, Xu Y. Hyperhomocysteinemia as a metabolic risk factor for glucose intolerance among high-risk groups of chinese adults.Med Sci Monit. 2017;23:2775–2781.
35. Bansal S, Kapoor S, Singh GP, Yadav S. Serum Homocysteine Levels in Type 2 Diabetes Mellitus Patients.International Jr of Contemporary Medical Research. 2016;3(11):3393–3396. Author biography Santosh Eknath BidweAssistant Professor Prashant J HisalkarProfessor and HOD Neerja MallickProfessor and Registrar